Pulmocide raised €28M in a Series B round in Mar 2017. The company is based in London, UK. Investors in the round: F Prime Capital, Johnson & Johnson, Johnson & Johnson Innovation and 3 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €28M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
